Advertisement

Evolution of HIV/AIDS Policy

  • Fan LuEmail author
  • Peng Xu
  • Jennifer M. McGoogan
  • Wanying Chen
  • Liping Ma
Chapter

Abstract

The HIV/AIDS-related policy framework in China has come a long way from initially attempting to prevent HIV from entering the country in the early stages of the epidemic to facilitating comprehensive national HIV response of today. Each step of the way, policymakers in China have strived to ensure that HIV-related policies were pragmatic, tailored to the Chinese context, aligned with international best practices, and based upon the best available information at the time. Although there have been a great many policy actions since HIV was first discovered on the mainland, a few key policies were foundational, had a major impact on the epidemic, and marked an important shift China’s HIV response, for example, the Blood Donation Law (1998), the first Five-Year Action Plan for the Containment and Control of HIV/AIDS (2001), and the “Four Frees and One Care” policy (2003). These and other key policies are highlighted here. Going forward, as China’s HIV epidemic increases in size and complexity, policymakers need to remain grounded in evidence but also be open to alternative and innovative approaches.

Notes

Acknowledgments

The author would like to thank Jonas Tillman for editorial assistance.

References

  1. Cao X, Sullivan SG, Xu J, Wu Z, China CIPRA Project 2 Team. Understanding HIV-related stigma and discrimination in a “blameless” population. AIDS Educ Prev. 2006;18(6):518–28.  https://doi.org/10.1521/aeap.2006.18.6.518.CrossRefGoogle Scholar
  2. Gu D, Mao Y, Tang Z, Montaner J, Shen Z, Zhu Q, et al. Loss to follow-up from HIV screening to ART initiation in rural China. PLoS One. 2016;11(10):e0164346.  https://doi.org/10.1371/journal.pone.0164346.CrossRefPubMedPubMedCentralGoogle Scholar
  3. He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013;8(11):e77981.  https://doi.org/10.1371/journal.pone.0077981.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Joint United Nations Programme on HIV/AIDS. “Three Ones” key principles. Geneva: Joint United Nations Programme on HIV/AIDS; 2004. http://data.unaids.org/una-docs/three-ones_keyprinciples_en.pdf. Accessed 25 Sep 2018.Google Scholar
  5. Joint United Nations Programme on HIV/AIDS. 90-90-90—an ambitious treatment target to help end the AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2014. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf. Accessed 27 Sep 2018.Google Scholar
  6. Joint United Nations Programme on HIV/AIDS. Ending AIDS—progress towards the 90-90-90 targets. Geneva: Joint United Nations Programme on HIV/AIDS; 2017. http://www.unaids.org/sites/default/ files/media_asset/Global_AIDS_update_2017_en.pdf. Accessed 27 Sep 2018.
  7. Lin W, Chen S, Seguy N, Chen Z, Sabin K, Calleja JG, et al. Is the HIV sentinel surveillance system adequate in China? Findings from an evaluation of the national HIV sentinel surveillance system. Western Pac Surveill Response J. 2012;3(4):76–85.  https://doi.org/10.5365/WPSAR.2012.3.3.004.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Ma Y, Li Z, Zhang K. Identification of HIV infection among drug users in China. Chinese J Epidemiol. 1990;11:184–5.Google Scholar
  9. Ma Y, Dou Z, Guo W, Mao Y, Zhang F, McGoogan JM, et al. The human immunodeficiency virus care continuum in China: 1985–2015. Clin Infect Dis. 2018;66(6):833–9.  https://doi.org/10.1093/cid/cix911.CrossRefGoogle Scholar
  10. Mao Y, Wu Z, Poundstone K, Wang C, Qin Q, Ma Y, et al. Development of a unified web-based national HIV/AIDS information system in China. Int J Epidemiol. 2010;39(Suppl 2):ii79–89.  https://doi.org/10.1093/ije/dyq213.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Ministry of Health. Notice on banning import of blood products such as factor VIII. Beijing: Ministry of Health, People’s Republic of China; 1984.Google Scholar
  12. Ministry of Health. Report on strengthening surveillance to prevent imported cases of HIV/AIDS. Beijing: Ministry of Health, People’s Republic of China; 1985.Google Scholar
  13. Ministry of Health. Notice on strengthening HIV/AIDS management. Beijing: Ministry of Health, People’s Republic of China; 1986.Google Scholar
  14. Ministry of Health. Working duty in HIV/AIDS prevention and control for related ministries, committees, administrations and social groups. Beijing: Ministry of Health, People’s Republic of China; 2000.Google Scholar
  15. Ministry of Health. Notice on HIV screening of former plasma donors. Beijing: Ministry of Health, People’s Republic of China; 2004.Google Scholar
  16. Ministry of Health, Ministry of Foreign Affairs, Ministry of Public Security. Several provisions concerning HIV surveillance and management. Beijing: Ministry of Health and Ministry of Public Security, People’s Republic of China; 1988.Google Scholar
  17. Ministry of Health, Ministry of Public Security. Provisions concerning the provision of health certificate by foreigners seeking entry. Beijing: Ministry of Health and Ministry of Public Security, People’s Republic of China; 1987.Google Scholar
  18. Ministry of Health, Ministry of Public Security. Notice on providing compulsory testing and treatment of sexual transmitted diseases for sex workers and their clients. Beijing: Ministry of Health and Ministry of Public Security, People’s Republic of China; 1991.Google Scholar
  19. Ministry of Health, Ministry of Public Security, Ministry of Justice. Notice on HIV screening of inmates of prisons and detoxification centers. Beijing: Ministry of Health, Ministry of Public Security, and Ministry of Justice, People’s Republic of China; 2004.Google Scholar
  20. Ministry of Health, State Development Planning Commission, Ministry of Science and Technology, Ministry of Finance. China’s medium and long-term plan on prevention and control of HIV/AIDS. Beijing: Ministry of Health, State Development Planning Commission, Ministry of Science and Technology, and Ministry of Finance, People’s Republic of China; 1998.Google Scholar
  21. Ministry of Public Security, Ministry of Foreign Affairs. Rules for implementation of the law of the People’s Republic of China on control of the entry and exit of aliens. Beijing: Ministry of Public Security and the Ministry of Foreign Affairs, People’s Republic of China; 1986.Google Scholar
  22. National Health and Family Planning Commission. 2015 China AIDS response progress report. Beijing: National Health and Family Planning Commission, People’s Republic of China; 2015. http://www.commuhealtibet.org/wp-content/uploads/2016/11/CHN_narrative_report_2015.pdf. Accessed 27 Sep 2018.Google Scholar
  23. Shao Y, Chen Z, Wang B, Zeng Y, Zhao SD, Zhang ZR. Isolation of viruses from HIV infected individuals in Yunnan. Chinese J Epidemiol. 1991;12:129.Google Scholar
  24. Standing Committee of the National People’s Congress. Blood donation law of the People’s Republic of China. Beijing: Standing Committee of the National People’s Congress, People’s Republic of China; 1998.Google Scholar
  25. State Council. China’s action plan for reducing and preventing the spread of HIV/AIDS (2001–2005). Beijing: State Council, People’s Republic China; 2001.Google Scholar
  26. State Council. Notice on strengthening AIDS prevention, treatment and care programs. Beijing: State Council, People’s Republic China; 2004.Google Scholar
  27. State Council. Regulations on AIDS prevention and treatment. Beijing: State Council, People’s Republic of China; 2006a.Google Scholar
  28. State Council. Action plan on HIV/AIDS prevention and containment (2006–2010). Beijing: State Council, People’s Republic of China; 2006b.Google Scholar
  29. State Council. Rules for implementation of the law of the People’s Republic of China on control of the entry and exit of aliens. Beijing: State Council, People’s Republic of China; 2010a.Google Scholar
  30. State Council. Notice on strengthening AIDS prevention, treatment and care programs. Beijing: State Council, People’s Republic China; 2010b.Google Scholar
  31. State Council. China’s action plan for reducing and preventing the spread of HIV/AIDS (2011–2015). Beijing: State Council, People’s Republic China; 2012.Google Scholar
  32. State Council. Thirteenth five-year action plan for controlling HIV/AIDS in China (2016–2020). Beijing: State Council, People’s Republic of China; 2017.Google Scholar
  33. State Education Commission, Ministry of Health. Notice on performing HIV test for foreign students. Beijing: State Education Commission and Ministry of Health, People’s Republic of China; 1986.Google Scholar
  34. Sun X, Lu F, Wu Z, Poundstone K, Zeng G, Xu P, et al. Evolution of information-driven HIV/AIDS policies in China. Int J Epidemiol. 2010;39(Suppl 2):ii4–13.  https://doi.org/10.1093/ije/dyq217.CrossRefPubMedPubMedCentralGoogle Scholar
  35. Wang N, Wang L, Wu Z, Guo W, Sun X, Poundstone K, et al. Estimating the number of people living with HIV/AIDS in China: 2003–09. Int J Epidemiol. 2010;39(Suppl 2):ii21–8.  https://doi.org/10.1093/ije/dyq209.CrossRefPubMedPubMedCentralGoogle Scholar
  36. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection—recommendations for a public health approach. Geneva: World Health Organization; 2016. http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=6EB9CCB5EDBD29972688DFFF0481ACF7?sequence=1. Accessed 27 Sep 2018.Google Scholar
  37. Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet. 1995;346(8966):61–2.CrossRefGoogle Scholar
  38. Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan. 2001;16:41–6.CrossRefGoogle Scholar
  39. Wu Z, Sullivan SG, Wang Y, Rotherum-Borus MJ, Detels R. The evolution of China’s response to HIV/AIDS. Lancet. 2007;369(9562):679–90.  https://doi.org/10.1016/S0140-6736(07)60315-8.CrossRefGoogle Scholar
  40. Wu Z, Dong N, Guo W. Discovery and control of the HIV/AIDS epidemic among plasma donors in China. In: Li LM, Zhan SY, editors. Epidemiological research cases in China. Beijing: People’s Medical Publishing House; 2008. p. 153–64.Google Scholar
  41. Wu Z, Xu J, Liu E, Mao Y, Xiao Y, Sun X, et al. HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis. 2013;57(2):298–309.  https://doi.org/10.1093/cid/cit210.CrossRefPubMedPubMedCentralGoogle Scholar
  42. Wu Z, Zhao Y, Ge X, Mao Y, Tang Z, Shi CX, et al. Simplified HIV testing and treatment in china: analysis of mortality rates before and after a structural intervention. PLoS Med. 2015;12(9):e1001874.  https://doi.org/10.1371/journal.pmed.1001874.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Wu Z, Tang Z, Mao Y, VanVeldhuisen P, Ling W, Liu D, et al. Testing and linkage to HIV care in China: a cluster-randomised trial. Lancet HIV. 2017;4(12):e555–65.  https://doi.org/10.1016/S2352-3018(17)30131-5.CrossRefPubMedPubMedCentralGoogle Scholar
  44. Zhang J, Chen H, Duan S, Duan Y, Zhao S, Wang S, et al. The epidemic of HIV infection in Yunnan (1989–1992). Chinese J Epidemiol. 1994;15:259–62.Google Scholar
  45. Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151(4):241–51.  https://doi.org/10.7326/0003-4819-151-4-200908180-00006.CrossRefGoogle Scholar
  46. Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516–24.  https://doi.org/10.1016/S1473-3099(11)70097-4.CrossRefGoogle Scholar
  47. Zhao Y, Shi CX, McGoogan JM, Rou K, Zhang F, Wu Z. Methadone maintenance treatment and mortality among HIV-positive people who inject opioids in China. Bull World Health Organ. 2013a;91(2):93–101.  https://doi.org/10.2471/BLT.12.108944.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Zhao Y, Li C, Sun X, Mu W, McGoogan JM, He Y, et al. Mortality and treatment outcomes of China’s National Pediatric Antiretroviral Therapy Program. Clin Infect Dis. 2013b;56(5):735–44.  https://doi.org/10.1093/cid/cis941.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Fan Lu
    • 1
    Email author
  • Peng Xu
    • 1
  • Jennifer M. McGoogan
    • 1
  • Wanying Chen
    • 1
  • Liping Ma
    • 1
  1. 1.NCAIDSChina CDCBeijingChina

Personalised recommendations